Rene Hurlemann, MD, PhD, MBA

  • Professor of Psychiatry and Psychotherapy

  • Chair of the Department of Psychiatry and Psychotherapy at the University of Oldenburg

  • Associate Dean for Strategic Development

  • Chief Medical Officer (CMO) of Karl Jaspers Clinic

  • Head of the Neuromodulation of Emotion (NEMO) Lab

Hurlemann 1.jpg

As the Chair of the Department of Psychiatry and Psychotherapy at the University of Oldenburg (Germany), and Chief Medical Officer (CMO) at the Karl Jaspers Clinic in Wehnen near Oldenburg, Professor Rene Hurlemann leads the second-largest maximum-care psychiatric hospital in Lower Saxony. Additionally, he serves as Associate Dean for Strategic Development at the School of Medicine and Life Sciences at the University of Oldenburg. Holding a PhD from Maastricht University, an MD from the University of Bonn, and an MBA from Frankfurt School of Finance & Management, Rene Hurlemann's professional journey is marked by academic excellence and commitment. His expertise in hospital management is centered on value-based healthcare (VBHC), a transformative approach focused on maximizing patient health outcomes while optimizing resource utilization. Rene Hurlemann leads an interdisciplinary research team dedicated to exploring the social determinants (e.g., loneliness) and environmental factors (e.g., climate change) that affect mental health. His mission is to transform these insights into technologically advanced, personalized clinical treatments, such as non-invasive neuromodulation with accelerated theta burst stimulation (TBS) and AI-based digital aftercare. Rene Hurlemann is an active member of several prestigious international societies, including the American College of Neuropsychopharmacology (ACNP) and the Society of Biological Psychiatry (SoBP). Additionally, he contributes to the editorial and advisory boards of several esteemed scientific journals, such as Der Nervenarzt (Springer Nature), Personalized Medicine in Psychiatry (Elsevier), Social Cognitive & Affective Neuroscience (SCAN) (Oxford Academic), and the Journal of Psychiatric Research (Elsevier).

Related links:

Recommended Reading:

  • Hurlemann R & Domschke K (2024) Challenging treatment resistance. Nervenarzt 95: 405 - 406 (article in German) PDF

  • Baune BT, Fromme SE, Kiebs M, Hurlemann R (2024) Clinical management of treatment-resistant depression. Nervenarzt 95: 416 - 422 (article in German) PDF

  • Rethinking mental healthcare: harnessing new approaches (2024) The Economist Impact PDF

Abbreviations: IF, Journal Impact Factor